Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: August 26, 2010
Last updated: September 30, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)